MENU CLOSE
About Us

Who We Are

Our Social Responsibility

Events

Exhibitions

Activeties

Members

Hospitals

Individuals

Companies

Member Benefits

 
Bio-medical projectsi

State Key Laboratory of Biotherapy

Cooperation

Achievement Exhibition

Scimea Journals

Signal Transduction and Targeted Therapy

News

News Information

 
Home   >  News
03 Sep 2020
501
MedComm | Transgenic zebrafish for modeling hepatocellular carcinoma
SCIMEA

Liver cancer is the third leading cause of cancer‐related deaths throughout the world, and more than 0.6 million people die from liver cancer annually. Therefore, novel therapeutic strategies to eliminate malignant cells from liver cancer patients are urgently needed. In this review, Prof. Joji Nakayama summarizes the current knowledge of epidemiological data and genetic alterations in hepatocellular carcinoma (HCC) and zebrafish models of HCC to help find potential therapeutic strategies for targeting HCC. 


image.png


Recent advances in high‐throughput genomic technologies have identified de novo candidates for oncogenes and pharmacological targets. However, testing and understanding the mechanism of oncogenic transformation as well as probing the kinetics and therapeutic responses of spontaneous tumors in an intact microenvironment require in vivo examination using genetically modified animal models. The zebrafish (Danio rerio) has attracted increasing attention as a new model for studying cancer biology since the organs in the model are strikingly similar to human organs and the model can be genetically modified in a short time and at a low cost. This review summarizes the current knowledge of epidemiological data and genetic alterations in hepatocellular carcinoma (HCC), zebrafish models of HCC, and potential therapeutic strategies for targeting HCC based on knowledge from the models (Fig. 1).


image.png


Fig. 1  Transgenic Zebrafish models of HCC



Article Access: https://onlinelibrary.wiley.com/doi/10.1002/mco2.29



Website for MedComm: https://onlinelibrary.wiley.com/journal/26882663

Looking forward to your contributions.





“Walk Hand in Hand with Companionship and Love” - Patients Care Series Activities of Clinical Research Center of Breast Diseases / Head and Neck Oncology, West China Hospital, Sichuan University
MedComm | Radiomics‐based model for accurately distinguishing between severe acute respiratory syndrome associated coronavirus 2 (SARS‐CoV‐2) and influenza A infected pneumonia
Ocular Eye Care Committee (OECC) of Sichuan International Medical Exchange & Promotion Association (SCIMEA) Was Estalished.
[Heroes In White] SCIMEA Invites a Student from West China Hospital, Sichuan University to Compose a Song to Pay Tribute to Frontline Medical Staff
"A Lie"
Latest Events Journals News Members About Us Home
Contact Us

Address: No. 1103-1105, Building 6, S2, Global Center, High-tech Zone, Chengdu

Email: scimea@163.com 

Tel: (0086-)028-63859818   

Fax: (0086-)028-63859818   

Contact: (0086-)19113901604 (wechat:19113901604)


Follow Us
Copyright © 2009-2019 SCIMEA. All rights reserved 蜀ICP备19011649号-1